|
|
|
40
|
12011
|
COSOPT 2% | 0.5% EYE DR (MSD/STO) DORZOLAMIDE | TIMOLOL
|
DORZOLAMIDE|TIMOLOL
|
COSOPT
|
5ML
|
C
|
24.76
|
24.76
|
EYE DROP
|
0
|
BOTT
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
12011
|
COSOPT 2%|0.5% EYE DR (MSD/STO) DORZOLA (C)
|
DORZOLAMIDE|TIMOLOL
|
COSOPT
|
5ML
|
C
|
24.76
|
24.76
|
EYE DROP
|
|
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2022-04-01
|
2022-12-31
|
Delete from contract
|
OPHTHALMIC
|
6
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2022-12-31
|
|
|
|
40
|
12012
|
GLAUCOTENSIL TD 2% | 0.5% EYE DR (LPO/COL) DORZ
|
DORZOLAMIDE|TIMOLOL
|
GLAUCOTENSIL TD
|
5ML
|
A
|
12.23
|
12.23
|
EYE DROP
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
12012
|
GLAUCOTENSIL TD 2%|0.5% EYE DR (LPO) DORZOLAMIDE|TIMOLOL
|
DORZOLAMIDE|TIMOLOL
|
GLAUCOTENSIL TD
|
5ML
|
A
|
13.46
|
13.4557
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
12012
|
GLAUCOTENSIL TD 2%|0.5% EYE DR (LPO) DORZOLAMIDE|TIMOLOL
|
DORZOLAMIDE|TIMOLOL
|
GLAUCOTENSIL TD
|
5ML
|
B
|
19.03
|
19.03
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
AVENTA BARBADOS
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
1201Q
|
DORZOL-T 2% | 0.5% EYE DR (CIR/AHI) DORZOLAMIDE
|
DORZOLAMIDE|TIMOLOL
|
DORZOL-T
|
10ML
|
A
|
21.61
|
21.61
|
EYE DROP
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Ophthalmic
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
1201S
|
ENDOR PLUS 2%|0.5% EYE DR (SYP) DORZOLAMIDE|TIMOLOL
|
DORZOLAMIDE|TIMOLOL
|
ENDOR PLUS
|
5ML
|
A
|
11.69
|
11.6888
|
BOTT
|
1
|
BOTT
|
SYP
|
SYAASH PHARMACEUTICALS
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
1201T
|
ENDOR PLUS 2%|0.5% EYE DR (SYP) DORZOLAMIDE|TIMOLOL
|
DORZOLAMIDE|TIMOLOL
|
ENDOR PLUS
|
5ML
|
A
|
12.48
|
12.48
|
BOTT
|
1
|
BOTT
|
SYP
|
SYAASH PHARMACEUTICALS
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
B
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
|